Analysis of Risk Factors for Secondary Endometrial Cancer-Related Death: A SEER-Based Study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Patients with second primary endometrial cancer (SPEC) have lower survival rates. Treatment with surgery for SPEC reduces mortality, while chemotherapy and radiotherapy increase it. Endometrial cancer itself is a significant risk factor for survival.
Area Of Science
- Gynecologic Oncology
- Cancer Epidemiology
- Survival Analysis
Background
- Endometrial cancer (EC) is a common gynecologic malignancy.
- Understanding survival outcomes for patients with a history of prior cancer is crucial.
- Second primary endometrial cancer (SPEC) presents unique challenges in management and prognosis.
Purpose Of The Study
- To analyze the survival of patients diagnosed with endometrial cancer after a prior cancer diagnosis.
- To identify risk factors associated with endometrial cancer death in this specific patient population.
- To compare survival outcomes between patients with single primary EC and those with SPEC.
Main Methods
- Utilized the SEER database to identify 1371 women diagnosed with SPEC between 2004 and 2015.
- Employed Fine and Gray regression and propensity score matching (PSM) to analyze treatment impacts and compare cohorts.
- Applied Kaplan-Meier and Cox survival models to assess the influence of prior cancer history on survival.
Main Results
- Patients with prior lung cancer had the lowest overall survival (OS).
- A diagnostic interval of ≥3 years for SPEC was linked to higher mortality.
- Surgical treatment for SPEC reduced mortality, while radiotherapy and chemotherapy increased it.
- SPEC patients exhibited significantly lower OS rates compared to single primary EC patients.
- Endometrial cancer, as either first primary cancer (FPC) or SPEC, was an independent risk factor for survival.
Conclusions
- Chemotherapy and radiotherapy for SPEC are associated with increased endometrial cancer-specific mortality (ECSM).
- Endometrial cancer, regardless of being FPC or SPEC, is a significant independent risk factor for overall survival (OS) and ECSS.
- Surgical intervention for SPEC appears to improve survival outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...